Showing results (51-60 of 69) with videos related to

Sort By:
Pageof 7
The Journal of Biological Chemistry|September 30, 2015
The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in CancerSalima Daou, Ian Hammond-Martel, Nazar Mashtalir, et al.
Journal of Natural Products|February 6, 2014
Study of marine natural products including resorcyclic acid lactones from Humicola fuscoatra that reactivate latent HIV-1 expression in an in vitro model of central memory CD4+ T cellsEric J Mejia, Steven T Loveridge, George Stepan, et al.
Organic Letters|January 7, 2015
Abyssomicin 2 reactivates latent HIV-1 by a PKC- and HDAC-independent mechanismBrian León, Gabriel Navarro, Bailey J Dickey, et al.
Cell Reports|April 18, 2019
Genome-Wide CRISPR-Cas9 Screens Expose Genetic Vulnerabilities and Mechanisms of Temozolomide Sensitivity in Glioblastoma Stem CellsGraham MacLeod, Danielle A Bozek, Nishani Rajakulendran, et al.
Antimicrobial Agents and Chemotherapy|September 21, 2016
Antiviral Activity of Bictegravir (GS-9883), a Novel Potent HIV-1 Integrase Strand Transfer Inhibitor with an Improved Resistance ProfileManuel Tsiang, Gregg S Jones, Joshua Goldsmith, et al.
Journal of Cell Science|February 2, 2020
A potent nuclear export mechanism imposes USP16 cytoplasmic localization during interphaseNadine Sen Nkwe, Salima Daou, Maxime Uriarte, et al.
Molecular Pharmaceutics|November 2, 2023
Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral AgentRaju Subramanian, Jennifer Tang, Jim Zheng, et al.
Journal of Medicinal Chemistry|May 15, 2020
Discovery of GS-9688 (Selgantolimod) as a Potent and Selective Oral Toll-Like Receptor 8 Agonist for the Treatment of Chronic Hepatitis BRichard L Mackman, Michael Mish, Gregory Chin, et al.
Plos Pathogens|April 12, 2014
Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosingDatsen George Wei, Vicki Chiang, Elizabeth Fyne, et al.
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery of Lanraplenib (GS-9876): A Once-Daily Spleen Tyrosine Kinase Inhibitor for Autoimmune DiseasesPeter Blomgren, Jayaraman Chandrasekhar, Julie A Di Paolo, et al.
Pageof 7